“Misbranded” Rosacea, Acne Treatments Targeted In FDA Warning Letters
This article was originally published in The Rose Sheet
Executive Summary
Bass & Boney's Rosacea-Ltd III, which labeling claims is "designed specifically for skin that is sensitive or inflamed due to rosacea and seborrheic dermatitis," is one of several skin care products targeted in a number of recent FDA warning letters